Eosinophilic asthma is high risk—denials often ignore that.

Appeal Your Nucala Asthma Denial

Eosinophilic asthma is high risk—denials often ignore that.

Understanding Your Nucala for Eosinophilic Asthma Denial

Nucala is denied when eosinophil counts are questioned, documentation is incomplete, or insurers want a different biologic first. Appeals can show that your eosinophilic asthma remains uncontrolled and at high risk without Nucala.

Common Reasons for Denial

  • ! Eosinophil counts not documented or not repeated
  • ! Asthma not labeled as eosinophilic or severe
  • ! Not enough steroid bursts or exacerbations documented
  • ! Preference for an alternative eosinophil-targeting biologic

How We Help

We help your clinician pull together lab trends, imaging, lung function, and exacerbation records to show why Nucala is medically necessary.

Some Types of Evidence We Can Use For Supporting Your Appeal

Mepolizumab reduces exacerbations and oral steroid use in patients with severe eosinophilic asthma.

Eosinophilic inflammation is a key driver of exacerbations in a subset of asthma patients.

Biologics targeting IL-5 or related pathways are standard options for severe eosinophilic asthma in guideline algorithms.

Patient Assistance & Copay Programs

These programs may help reduce your costs while you appeal:

NUCALA Copay Program

Pay as little as $0 with commercial insurance. Up to $15,000/year benefit.

GSK Patient Assistance Foundation

Free medication for qualifying uninsured patients or those with Medicare.

Eligibility requirements and program terms may change. Please verify current details directly with each organization.

Patient Advocacy & Support Organizations

These organizations provide education, support, and advocacy for patients:

Asthma and Allergy Foundation of America

Leading patient advocacy organization for asthma and allergies, certified by National Health Council.

Allergy & Asthma Network

Nonprofit patient outreach, education, advocacy and research organization.

Frequently Asked Questions

Multiple measurements can help. Your appeal can include both historical and recent labs, especially if steroids temporarily lowered counts.

Your clinician can connect lab values, nasal or sinus disease, and response to steroids with the diagnosis of eosinophilic asthma.

Ready to Fight Your Nucala for Eosinophilic Asthma Denial?

Our free AI-powered tool will help you generate a compelling appeal letter in minutes.

Disclaimer: Fight Health Insurance is not affiliated with, endorsed by, or partnered with any pharmaceutical manufacturer, healthcare provider, medical device company, or patient assistance program. All information provided is for educational and informational purposes only and does not constitute medical or legal advice. Please consult with your healthcare provider regarding treatment options and with your insurance company regarding coverage decisions.